Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Mi Bonde

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Molecular and Cellular Cardiology|October 14, 2008
Molecular determinants of angiotensin II type 1 receptor functional selectivityMark Aplin, Marie Mi Bonde, Jakob Lerche Hansen
Endocrine, Metabolic & Immune Disorders Drug Targets|April 14, 2006
Family C 7TM receptor dimerization and activationMarie Mi Bonde, Søren P Sheikh, Jakob Lerche Hansen
Nucleic Acids Research|October 30, 2014
Quantification of pre-mRNA escape rate and synergy in splicingMarie Mi Bonde, Sylvia Voegeli, Antoine Baudrimont, et al.
Plos One|December 15, 2010
Biased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanismsMarie Mi Bonde, Jonas Tind Hansen, Samra Joke Sanni, et al.
Regulatory Peptides|December 1, 2010
The angiotensin II type 1 receptor antagonist Losartan binds and activates bradykinin B2 receptor signalingMarie Mi Bonde, Kristine Boisen Olsen, Niels Erikstrup, et al.
The Cochrane Database of Systematic Reviews|December 8, 2021
Monitoring strategies for clinical intervention studiesKatharina Klatte, Christiane Pauli-Magnus, Sharon B Love, et al.
Plos One|July 18, 2017
Towards the development of a comprehensive framework: Qualitative systematic survey of definitions of clinical research qualityBelinda von Niederhäusern, Stefan Schandelmaier, Marie Mi Bonde, et al.
Biochemical Pharmacology|March 16, 2010
An angiotensin II type 1 receptor activation switch patch revealed through evolutionary trace analysisMarie Mi Bonde, Rong Yao, Jian-Nong Ma, et al.
European Journal of Pharmacology|June 21, 2008
The human angiotensin AT(1) receptor supports G protein-independent extracellular signal-regulated kinase 1/2 activation and cellular proliferationJakob Lerche Hansen, Mark Aplin, Jonas Tind Hansen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Molecular and Cellular Cardiology|October 14, 2008
Molecular determinants of angiotensin II type 1 receptor functional selectivityMark Aplin, Marie Mi Bonde, Jakob Lerche Hansen
Endocrine, Metabolic & Immune Disorders Drug Targets|April 14, 2006
Family C 7TM receptor dimerization and activationMarie Mi Bonde, Søren P Sheikh, Jakob Lerche Hansen
Nucleic Acids Research|October 30, 2014
Quantification of pre-mRNA escape rate and synergy in splicingMarie Mi Bonde, Sylvia Voegeli, Antoine Baudrimont, et al.
Plos One|December 15, 2010
Biased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanismsMarie Mi Bonde, Jonas Tind Hansen, Samra Joke Sanni, et al.
Regulatory Peptides|December 1, 2010
The angiotensin II type 1 receptor antagonist Losartan binds and activates bradykinin B2 receptor signalingMarie Mi Bonde, Kristine Boisen Olsen, Niels Erikstrup, et al.
The Cochrane Database of Systematic Reviews|December 8, 2021
Monitoring strategies for clinical intervention studiesKatharina Klatte, Christiane Pauli-Magnus, Sharon B Love, et al.
Plos One|July 18, 2017
Towards the development of a comprehensive framework: Qualitative systematic survey of definitions of clinical research qualityBelinda von Niederhäusern, Stefan Schandelmaier, Marie Mi Bonde, et al.
Biochemical Pharmacology|March 16, 2010
An angiotensin II type 1 receptor activation switch patch revealed through evolutionary trace analysisMarie Mi Bonde, Rong Yao, Jian-Nong Ma, et al.
European Journal of Pharmacology|June 21, 2008
The human angiotensin AT(1) receptor supports G protein-independent extracellular signal-regulated kinase 1/2 activation and cellular proliferationJakob Lerche Hansen, Mark Aplin, Jonas Tind Hansen, et al.
Pageof 1